NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17 Cr | ₹7.87 Cr | ₹3.19 Cr | ₹3.28 Cr | ₹1.79 Cr |
What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹7.87 Cr |
| Mar2023 | ₹3.19 Cr |
| Mar2022 | ₹3.28 Cr |
| Mar2013 | ₹1.79 Cr |
How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 110.04 | |
| Mar2024 | ₹7.87 Cr | 146.55 | |
| Mar2023 | ₹3.19 Cr | -2.60 | |
| Mar2022 | ₹3.28 Cr | 82.96 | |
| Mar2013 | ₹1.79 Cr | - | |
Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹290.1 Cr | 0.2% | -5.3% | -23.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,272.7 Cr | 2% | 2.2% | -17.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,004.0 Cr | 0.5% | -4.7% | 4.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,018.2 Cr | -0.4% | 7.7% | -23.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,077.0 Cr | 0.6% | -7.7% | -34.8% | Stock Analytics | |
| INDO US BIOTECH | ₹249.2 Cr | -1.1% | -1.6% | -65.1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 0.2% |
-5.3% |
-23.4% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses